The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / C••••••• S••••••• M•••••••••

G•••• P•••• Partners Completes Growth Recapitalization of C••••••• S••••••• M••••••••• - G•••• P•••• Partners

Majority recapitalizationclosedannounced Oct 12, 2016closed Oct 12, 2016Fact
What happened
Target
C••••••• S••••••• M•••••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / clinic
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • R•••• S•••••Deal partnerconfirmed
    ““CSM has a superb reputation in the clinical trial management industry and is constantly evolving to meet the needs of their clients,” said R•••• S•••••, Principal of G•••• P•••• Partners.”
  • S•••••• W•••••Deal partnerconfirmed
    ““Gerald has done a phenomenal job leading CSM through two decades of growth” added S•••••• W•••••, Vice President of G•••• P•••• Partners.”
  • G•••• P•••• P•••••••• L••Sponsorconfirmed
    “G•••• P•••• Partners (“GPP”) today announced a growth recapitalization of C••••••• S••••••• M••••••••• (“CSM” or the “Company”). | published on G•••• P•••• Partners's own news page www.gppfunds.com”
Side not stated
Evidence
“G•••• P•••• Partners (“GPP”) today announced a growth recapitalization of C••••••• S••••••• M••••••••• (“CSM” or the “Company”).”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 20, 2026
G•••• P•••• Partners Completes Growth Recapitalization of C••••••• S••••••• M••••••••• - G | Private Equity Intelligence | DFX